Stockscreener 앱 받기
1.72
4.44%
-0.08
시간 외 거래:
1.72
전일 마감가:
$1.80
열려 있는:
$1.77
하루 거래량:
243.86K
Relative Volume:
0.26
시가총액:
$45.73M
수익:
$155.00K
순이익/손실:
$-30.01M
주가수익비율:
-1.0299
EPS:
-1.67
순현금흐름:
$-11.98M
1주 성능:
-5.49%
1개월 성능:
-17.31%
6개월 성능:
-77.84%
1년 성능:
-72.48%
1일 변동 폭
$1.71
$1.79
1주일 범위
$1.71
$1.9262
52주 변동 폭
$1.71
$11.64
Inmune Bio Inc Stock (INMB) Company Profile
명칭
Inmune Bio Inc
전화
(858) 964-3720
주소
225 NE MIZNER BLVD, SUITE 640, BOCA RATON, CA
INMB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INMB
Inmune Bio Inc
|
1.72 | 47.85M | 155.00K | -30.01M | -11.98M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Inmune Bio Inc Stock (INMB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-01 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2025-07-01 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Underperform |
| 2025-01-28 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-21 | 개시 | Alliance Global Partners | Buy |
| 2024-09-27 | 개시 | Raymond James | Outperform |
| 2024-08-22 | 개시 | Scotiabank | Sector Outperform |
| 2023-06-01 | 개시 | Robert W. Baird | Outperform |
| 2022-05-24 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2021-07-07 | 재확인 | Maxim Group | Buy |
| 2021-04-21 | 개시 | B. Riley Securities | Buy |
| 2021-01-22 | 재확인 | Maxim Group | Buy |
| 2020-09-01 | 개시 | BTIG Research | Buy |
| 2020-07-15 | 재확인 | H.C. Wainwright | Buy |
모두보기
Inmune Bio Inc 주식(INMB)의 최신 뉴스
Heatmap analysis for INmune Bio Inc. and competitorsWeekly Investment Summary & Daily Volume Surge Trade Alerts - newser.com
Sentiment analysis tools applied to INmune Bio Inc.2025 Trade Ideas & High Conviction Investment Ideas - newser.com
Analyzing recovery setups for INmune Bio Inc. investorsWeekly Gains Report & Risk Controlled Swing Alerts - newser.com
Sector ETF performance correlation with INmune Bio Inc.July 2025 Levels & Reliable Momentum Entry Alerts - newser.com
How INmune Bio Inc. stock benefits from global expansionQuarterly Portfolio Report & Real-Time Volume Analysis - newser.com
Short interest data insights for INmune Bio Inc.Trade Risk Assessment & Fast Gain Stock Tips - newser.com
Is INmune Bio Inc. stock overvalued by current metricsIPO Watch & Safe Capital Growth Trade Ideas - newser.com
Is INmune Bio Inc. a candidate for recovery playTreasury Yields & Fast Entry Momentum Trade Alerts - newser.com
Does INmune Bio Inc. stock trade at a discount to peersMarket Risk Analysis & Free Fast Gain Swing Trade Alerts - newser.com
Statistical indicators supporting INmune Bio Inc.’s strengthEarnings Overview Report & Short-Term High Return Ideas - newser.com
What makes INmune Bio Inc. stock attractive to growth fundsQuarterly Profit Review & Stock Portfolio Risk Control - newser.com
Earnings visualization tools for INmune Bio Inc.Rate Cut & Safe Entry Point Identification - newser.com
Published on: 2025-11-02 21:20:18 - newser.com
Published on: 2025-11-02 20:37:16 - newser.com
Can volume confirm reversal in INmune Bio Inc.2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
Inmune Bio Reports Q3 2025 Financial Results - MSN
How INmune Bio Inc. stock reacts to Fed rate cutsPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
INmune Bio, Inc. (NASDAQ:INMB) Q3 2025 Earnings Call Transcript - Insider Monkey
Will INmune Bio Inc. stock outperform tech sector in 2025Treasury Yields & Daily Chart Pattern Signal Reports - newser.com
Inmune Bio to Host Q3 Results Conference Call - MSN
What analysts say about INmune Bio Inc stockMarket Liquidity Analysis & High Return Trading Ideas - earlytimes.in
Candlestick signals on INmune Bio Inc. stock todayWeekly Trading Summary & AI Optimized Trade Strategies - newser.com
Earnings call transcript: INmune Bio beats Q3 2025 EPS forecast, stock dips - Investing.com Australia
Earnings call transcript: INmune Bio beats Q3 2025 EPS forecast, stock dips By Investing.com - Investing.com South Africa
Inmune Bio outlines 2026 regulatory milestones and cash runway through Q4 2026 - MSN
Is it time to cut losses on INmune Bio Inc.Weekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com
Transcript : INmune Bio, Inc., Q3 2025 Earnings Call, Oct 30, 2025 - MarketScreener
INmune Bio Inc (INMB) Q3 2025 Earnings Call Highlights: Regulatory Progress and Financial ... - Yahoo Finance
INmune Bio Inc (INMB) Q3 2025 Earnings Call Highlights: Regulato - GuruFocus
INmune Bio Shrinks Losses While Analysts See Upside Ahead - Finimize
INMB Maintains Strong Cash Position with $27.7 Million on Hand - GuruFocus
Inmune Bio Inc (INMB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):